tiprankstipranks
Trending News
More News >
Supernus Pharmaceuticals (SUPN)
:SUPN
US Market

Supernus Pharmaceuticals (SUPN) Ownership - Who Owns Supernus Pharmaceuticals?

Compare
535 Followers

Supernus Pharmaceuticals (SUPN) Ownership Overview

4.29%31.80%24.11%26.86%12.94%
24.11% Other Institutional Investors
26.86% ETFs
12.94% Public Companies and
Individual Investors
The ownership structure of Supernus Pharmaceuticals (SUPN) stock is a mix of institutional, retail, and individual investors. Approximately 82.77% of the company’s stock is owned by Institutional Investors, 4.29% is owned by Insiders, and 12.94% is owned by Public Companies and Individual Investors.
The ownership structure of Supernus Pharmaceuticals (SUPN) stock is a mix of institutional, retail, and individual investors. Approximately 55.91% of the company’s stock is owned by Institutional Investors, 4.29% is owned by Insiders, and 26.86% is owned by Public Companies and Individual Investors.

Recent Insider Trading Activity

Date
Name
Activity
Value
Oct 10, 2025
xxxxxxxxxxxxx
$3029336
Oct 03, 2025
xxxxxxxxxxxxx
$91506
Oct 02, 2025
xxxxxxxxxxxxx
$1931116
Oct 01, 2025
xxxxxxxxxxxxx
$414371

Recent Hedge Fund Trading Activity

Top Shareholders

Holder
# of Shares
Type
% Holding
Value
6,383,226Institution11.13%311,182,268
5,126,469Institution8.94%249,915,364
4,363,748Institution7.61%212,732,715
3,911,497Institution6.82%190,685,479
2,212,178Insider3.86%107,843,678
1,716,422Institution2.99%83,675,573
1,263,811Institution2.20%61,610,786
1,025,257Institution1.79%49,981,279
854,114Institution1.49%41,638,058
833,816Institution1.45%40,648,530

Top Mutual Fund Holders

Holder
# of Shares
Type
% Holding
Value
4,363,748Institution7.61%212,732,715
3,911,497Institution6.82%190,685,479
1,716,422Institution2.99%83,675,573
854,114Institution1.49%41,638,058
614,041Institution1.07%29,934,499
559,600Institution0.98%27,280,500
521,347Institution0.91%25,415,666
375,471Institution0.65%18,304,211
358,847Institution0.63%17,493,791
320,674Institution0.56%15,632,858

Top ETF Holders

Holder
# of Shares
Type
% Holding
Value
3,351,953Institution5.85%163,407,709
1,690,315Institution2.95%77,061,461
1,430,097Institution2.49%69,717,229
1,252,099Institution2.18%57,083,193
806,549Institution1.41%36,770,569
598,012Institution1.04%27,263,367
497,453Institution0.87%24,036,929
434,418Institution0.76%21,177,878
270,496Institution0.47%13,070,367
265,665Institution0.46%12,111,667

FAQ

Who Owns Supernus Pharmaceuticals (SUPN)?
According to the latest TipRanks data, approximately 24.11% of the company's stock is held by institutional investors, 4.29% is held by insiders, and 12.94% is held by retail investors.
    What percentage of Supernus Pharmaceuticals (SUPN) stock is held by institutional investors?
    According to the latest TipRanks data, approximately 24.11% of Supernus Pharmaceuticals (SUPN) stock is held by institutional investors.
      What percentage of Supernus Pharmaceuticals (SUPN) stock is held by retail investors?
      According to the latest TipRanks data, approximately 12.94% of Supernus Pharmaceuticals (SUPN) stock is held by retail investors.
        Who owns the most shares of Supernus Pharmaceuticals (SUPN)?
        iShares owns the most shares of Supernus Pharmaceuticals (SUPN).
          What is the significance of the ownership structure for a publicly traded company?
          The ownership structure can impact the company's decision making, as large institutional investors may exert influence on the company's management and can also affect the company's stock price with their buying and selling patterns.